Valeant Pharmaceuticals Message Board


What's the Strategy in the U.S. for Neovasc's Reducer?

5 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

Valeant Layoffs

6 months ago

Layoffs in Derm will be continuous, but we already knew that.

Bausch Health is still Valeant

2 years ago

The name change still cracks me up. Will consumers and investors forget the past?

Dermatology

2 years ago

Grow derm sales team by 25% and then get a CRL for Duobrii, one of the "significant seven," apparently the seven drugs that are going to turn around Valeant. Don't bother with the fact that combined all of those drugs bring in less than $100 million in revenue. But they will generate over $1 billion within 5 years.

Oh boy! I've heard that before!!!

Papa's response -

"We are working to resolve this matter expeditiously and have already requested a meeting with the FDA," Valeant CEO Joseph Papa sai…

Valeant turnaround won't work but layoffs will

2 years ago

Someone has to take responsibility for my $$$$-ups!!!

-(Your)Papa

Time for Old man to leave

2 years ago

Isn't Thurman buddies with Calvert? Tough to see Thurman letting him go.

Top 10 Valeant products by revenue

2 years ago

You know there's a problem with your company when Wellbutrin is one of your best selling products.

It was approved in 1985!!!

Rifamycin

2 years ago

Going along with the Valeant strategy, maybe they pick up Cosmo?

Valeant Layoffs

2 years ago

And that same hedge fund run by Bill Ackman just had layoffs, probably because of his failures with Valeant. My favorite was that he had to let his personal driver go.

Loading...